Home > News > Headline News


Please Note

Some news stories may require you to register or sign in.  MedPage, for example, has an easy and free subscription form that only needs to be completed once--well worth the effort to access their timely and important articles.

Click on title to read the full article.

First-in-class antibody-drug conjugate shows clinical benefit against metastatic triple-negative breast cancer

November 9, 2015

By Medical Express

IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable, and yielded meaningful clinical activity in heavily pretreated patients with metastatic triple-negative breast cancer (TNBC)

The DeAngelo Williams Foundation and Susan G. Komen® Join Forces for New Campaign Extending Breast Cancer Fight beyond October

November 4, 2015

By Business Wire

“DeAngelo has proven time and again that he’s committed to reducing these death rates by raising funds for research, education, and access to quality cancer care for all women. We are so grateful to have such a dedicated and passionate player as a partner in our mission to end breast cancer forever.”

Study: Mammograms haven't cut rate of Advanced Breast Cancer

November 3, 2015

By The New England Journal of Medicine Marilynn Marchione The Associated Press

A new report raises fresh questions, suggesting that screening and early detection are not preventing the most dangerous forms of the disease. This should be posted soon on the New England Journal of Medicine website.

A Different World: Metastatic Breast Cancer

October 25, 2015

By Cure Magazine

There are now more experimental options than ever: New treatments that target the immune system, like the one Blachowiak takes, enlist a patient’s immune cells to fight the cancer, and could be a game-changer for “triple-negative” breast cancer, one of the hardest to treat.

Marker may predict risk of breast cancer spreading to the brain

October 22, 2015

By University of Wisconsin-Madison

A UW-Madison scientist working with an international team of researchers has developed a new tumor marker test that may help predict whether breast cancer is likely to spread or metastasize to the brain, a deadly complication with survival typically measured only in months after diagnosis.University of Wisconsin-Madison

Blackwell Discusses Emerging HER2-Positive Breast Cancer Agents

October 20, 2015

By OncLive

Emerging therapies are advancing through the pipeline in HER2-positive breast cancer, potentially giving oncologists options beyond some of the current treatments, such as pertuzumab (Perjeta), trastuzumab (Herceptin), and ado-trastuzumab emtansine (T-DM1; Kadcyla).

Javier Cortés, MD, on the CLEOPATRA Trial

October 15, 2015

By Oncology Journal

One of the most amazing results from the CLEOPATRA study was the overall survival (OS) data.

The Next Promising Frontier of Precision Medicine: Metastatic Breast Cancer

October 15, 2015

By Marc Hulbert PhD

One of the most promising frontiers for precision medicine is research in metastatic breast cancer.

PANVAC plus docetaxel may have clinical benefit for metastatic breast cancer

October 9, 2015

By Healio HemOnc Today

The addition of a poxviral-based cancer vaccine, or PANVAC, to docetaxel may confer a clinical benefit for patients with metastatic breast cancer, according to the results of a randomized phase 2 study.

Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast ...

October 8, 2015

By FDA Today

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer
‹ First  < 3 4 5 6 7 >  Last ›